Exagen Inc. (XGN) — SC 13G/A Filings
All SC 13G/A filings from Exagen Inc.. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Dec 12, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 13, 2024
- SC 13G/A Filing — Feb 13, 2024
-
Wasatch Advisors LP Cuts Exagen Stake to 4.9%
— Feb 9, 2024 Risk: medium
Wasatch Advisors LP, an investment adviser, filed an amended Schedule 13G/A on February 9, 2024, indicating a decrease in their ownership of Exagen Inc. common -
Cowen Financial Products Reports 898,630 Share Stake in Exagen Inc.
— Feb 2, 2024
Cowen Financial Products LLC, a New York-based financial firm, has updated its ownership stake in Exagen Inc. (NASDAQ: XGN), a medical laboratories company, as -
NMSIC Co-Investment Fund Updates Exagen Stake; Shifts Reporting Status
— Jan 22, 2024
NMSIC Co-Investment Fund, L.P. filed an amendment (SC 13G/A) on January 22, 2024, updating its ownership in Exagen Inc. as of December 31, 2023. This filing ind
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX